AAOS: Header Ban Linked to Decrease in Soccer-Linked Concussions in Children

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on March 12, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, March 12, 2025 -- Introduction of the United States Soccer Federation (USSF) header ban for athletes aged 10 years and younger in 2015 was associated with a reduction in the number of concussions as a percentage of all soccer-related injuries, according to a study presented at the annual meeting of the American Academy of Orthopaedic Surgeons, held from March 10 to 14 in San Diego.

Georgia Rose Sullivan, from the Mayo Clinic in Scottsdale, Arizona, and colleagues conducted a retrospective cohort study using data from the National Electronic Injury Surveillance System to examine whether the USSF header ban policy affected soccer-related concussions. For all soccer-related emergency department visits between Jan. 1, 2012, and Dec. 31, 2023, age, sex, and injury type were extracted. Concussions as a percentage of soccer-related injuries were assessed based on sex, age group, and year.

The researchers observed a decrease in the number of concussions as a percentage of all soccer-related injuries, from 8.2 percent in 2012 to 2015 to 6.1 percent in 2020 to 2023. There were decreases of 3.1, 1.7, and 0.5 percent in the concussion rate among those aged 14 to 17 years, 10 to 13 years, and 6 to 9 years, respectively. The concussion rates among 14- to 17-year-olds and 10- to 13-year-olds were higher than in 6- to 9-year-olds from 2012 to 2023 (8.9 and 6.6 percent, respectively, versus 4.9 percent). Girls were diagnosed with a greater proportion of concussions than boys despite a lower soccer-related injury rate overall (9.6 versus 6.2 percent).

"The USSF youth soccer header ban policy introduced in 2015 was associated with a 25.6 percent relative risk reduction to sustain a soccer-related concussion and present to the emergency department in 2020 to 2023 compared to 2012 to 2015," the authors write.

Press Release

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-03-13 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords